ERBB3 and gastric cancer: This method is for implementation in clinical study for better understanding of the correlation between HER-3, HER-4, with HRG-α quantities, in order to facilitate the early detection of gastric cancer, to adopt a personalized treatment, and to determine as soon as possible if the treatment given to the patient is efficient or not.